Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke
Prospective, Multicenter, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke
Sponsor: Suzhou Hengruihongyuan Medical Technology Co. LTD
Listed as NCT05719688, this NA trial focuses on Acute Ischemic Stroke and remains completed. Sponsored by Suzhou Hengruihongyuan Medical Technology Co. LTD, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
5 versions recorded-
Aug 2025 — Present [monthly]
Completed NA
Status: Unknown → Completed
-
Feb 2025 — Aug 2025 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2023 — Jul 2024 [monthly]
Recruiting NA
First recorded
Dec 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Suzhou Hengruihongyuan Medical Technology Co. LTD
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Changzhou, China, Dalian, China, Guangzhou, China, Hangzhou, China, Jiaxing, China, Lishui, China, Nanchang, China, Qingdao, China, Shanghai, China, Suzhou, China and 6 more location s